Company news

Establishment Labs Holdings Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Establishment Labs to Announce Second Quarter 2024 Financial Results on August 6

July 23, 2024

Establishment Labs Announces Participation in Two Upcoming Investment Conferences

May 22, 2024

Establishment Labs Reports First Quarter 2024 Financial Results

May 7, 2024

Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2024

May 1, 2024

Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America

April 30, 2024

Establishment Labs to Announce First Quarter 2024 Financial Results on May 8

April 23, 2024

Establishment Labs Announces Participation in The Aesthetic Meeting 2024

April 16, 2024

Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance

February 27, 2024

Establishment Labs Announces Amended Credit Facility with Oaktree

February 21, 2024

Establishment Labs to Announce Fourth Quarter 2023 Financial Results on February 28

February 13, 2024

Establishment Labs Announces Commercial Launch of Motiva Implants in China

January 21, 2024

Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023

January 8, 2024

Establishment Labs Announces First U.S. Commercial Procedure with Motiva Flora Tissue Expander

January 1, 2024

Establishment Labs to Present at the 42nd Annual J.P. Morgan Healthcare Conference

December 27, 2023

Establishment Labs Announces National Medical Products Administration Approval for Motiva Implants in China

November 8, 2023

Establishment Labs Reports Third Quarter 2023 Financial Results

November 6, 2023

Establishment Labs to Announce Third Quarter 2023 Financial Results on November 7

October 24, 2023

Establishment Labs Announces FDA Clearance of Motiva Flora SmoothSilk Tissue Expander

October 15, 2023

Establishment Labs Announces Two-Year Mia Femtech Clinical Results and the Launch of Zen at 8th World Symposium on Ergonomic Implants

October 12, 2023

Establishment Labs Reports Record Second Quarter 2023 Financial Results

August 7, 2023

Establishment Labs to Announce Second Quarter 2023 Financial Results on August 8

July 25, 2023

Establishment Labs Celebrates Opening of Sulàyöm Innovation Campus and Outlines New and Expanded Capabilities

July 18, 2023

Establishment Labs to Participate in Two Upcoming Investor Conferences

May 30, 2023

Establishment Labs Announces CE Mark Approval for Minimally Invasive Surgical Tools

May 29, 2023

Establishment Labs Reports Record First Quarter 2023 Financial Results

May 7, 2023

Establishment Labs Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares

April 26, 2023

Establishment Labs to Announce First Quarter 2023 Financial Results on May 8

April 25, 2023

Establishment Labs Announces Proposed Public Offering of Common Shares

April 23, 2023

Establishment Labs Announces Pricing of Public Offering of Common Shares

April 23, 2023

Establishment Labs Announces Preliminary Unaudited Results for First Quarter 2023

April 23, 2023

Establishment Labs Notes Presentation of 3-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2023

April 19, 2023

Establishment Labs Begins a New Era in Breast Aesthetics with Launch of Mia Femtech in Japan

April 9, 2023

Establishment Labs Announces Participation in The Aesthetic Meeting 2023

April 2, 2023

Establishment Labs Surpasses Three Million Motiva Devices

March 28, 2023

Establishment Labs Announces First Mia Femtech™ Partners in Europe and Second Partner Chain in Japan

March 22, 2023

Establishment Labs to Present at the Cowen 43rd Annual Health Care Conference

February 27, 2023

Establishment Labs Submits Module Four to U.S. FDA for Premarket Approval of Motiva and Reports Record Fourth Quarter and Full Year 2022 Financial Results

February 26, 2023

Establishment Labs to Announce Fourth Quarter 2022 Financial Results on February 27

February 12, 2023

Establishment Labs Announces Preliminary Unaudited Revenue for Fourth Quarter and Fiscal Year 2022

January 8, 2023

Establishment Labs Announces Seishin Plastic and Aesthetic Surgery Clinic in Japan as First Clinic Partner in Global Launch of Mia Femtech™

January 2, 2023

Establishment Labs to Participate in 41st Annual J.P. Morgan Healthcare Conference

December 27, 2022

Establishment Labs Announces Japanese Regulatory Approval and Reimbursement for Motiva Implants and the Motiva Flora Tissue Expander for Use in Post-Mastectomy Reconstruction

November 9, 2022

Establishment Labs Reports Third Quarter 2022 Financial Results

November 6, 2022

Establishment Labs to Announce Third Quarter 2022 Financial Results on November 7

October 23, 2022

Establishment Labs to Host Investor Event for Mia Femtech on October 5, 2022

September 19, 2022

Establishment Labs Announces Hani Zeini has Joined the Company as Exclusive Advisor in Anticipation of US Launch

September 11, 2022

Establishment Labs Reports Record Second Quarter 2022 Financial Results

August 7, 2022

Establishment Labs Announces Complete Enrollment in Motiva US IDE Study

August 2, 2022

Establishment Labs to Announce Second Quarter 2022 Financial Results on August 8

July 24, 2022

Establishment Labs Releases 2021 Sustainability Review

July 18, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 24 calls. Every call is listed under its year.

Decks

The 5 newest of 8 decks. Every deck is listed under its year.